Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis

Background Joint destruction is a hallmark of autoantibody-positive rheumatoid arthritis (RA), though the severity is highly variable between patients. The processes underlying these interindividual differences are incompletely understood. Methods We performed a genome-wide association study on the radiological progression rate in 384 autoantibody-positive patients with RA. In stage-II 1557 X-rays of 301 Dutch autoantibody-positive patients with RA were studied and in stage-III 861 X-rays of 742 North American autoantibody-positive patients with RA. Sperm-Associated Antigen 16 (SPAG16) expression in RA synovium and fibroblast-like synoviocytes (FLS) was examined using Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR) and immunohistochemistry. FLS secrete metalloproteinases that degrade cartilage and bone. SPAG16 genotypes were related to matrix metalloproteinase (MMP)-3 and MMP-1 expression by FLS in vitro and MMP-3 production ex vivo. Results A cluster of single nucleotide polymorphisms (SNPs) at 2q34, located at SPAG16, associated with the radiological progression rate; rs7607479 reached genome-wide significance. A protective role of rs7607479 was replicated in European and North American patients with RA. Per minor allele, patients had a 0.78-fold (95% CI 0.67 to 0.91) progression rate over 7 years. mRNA and protein expression of SPAG16 in RA synovium and FLS was verified. FLS carrying the minor allele secreted less MMP-3 (p=1.60×10−2). Furthermore, patients with RA carrying the minor allele had lower serum levels of MMP-3 (p=4.28×10−2). In a multivariate analysis on rs7607479 and MMP-3, only MMP-3 associated with progression (p=2.77×10−4), suggesting that the association between SPAG16-rs7607479 and joint damage is mediated via an effect on MMP-3 secretion. Conclusions Genetic and functional analyses indicate that SPAG16 influences MMP-3 regulation and protects against joint destruction in autoantibody-positive RA. These findings could enhance risk stratification in autoantibody-positive RA.

[1]  A. Zhernakova,et al.  Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis , 2012, Annals of the rheumatic diseases.

[2]  R. Tsonaka,et al.  Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study , 2012, Annals of the rheumatic diseases.

[3]  Posthumus,et al.  Genetic variants in IL-15 associate with progression of joint destruction in rheumatoid arthritis, a multi cohort study , 2012 .

[4]  K. Steinsson,et al.  Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population-based study , 2012, Annals of the rheumatic diseases.

[5]  Zhibing Zhang,et al.  Spag16, an Axonemal Central Apparatus Gene, Encodes a Male Germ Cell Nuclear Speckle Protein that Regulates SPAG16 mRNA Expression , 2011, PloS one.

[6]  T. Pap,et al.  Therapeutic opportunities in fibroblasts in inflammatory arthritis. , 2010, Best practice & research. Clinical rheumatology.

[7]  D. M. van der Heijde,et al.  How to avoid phenotypic misclassification in using joint destruction as an outcome measure for rheumatoid arthritis? , 2010, Rheumatology.

[8]  G. Firestein,et al.  Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis , 2010, Immunological reviews.

[9]  R. Plenge,et al.  Recent progress in rheumatoid arthritis genetics: one step towards improved patient care , 2009, Current opinion in rheumatology.

[10]  P. Tak,et al.  Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. , 2008, Arthritis and rheumatism.

[11]  P. Stinissen,et al.  Autoantibody Profiling in Multiple Sclerosis Reveals Novel Antigenic Candidates1 , 2008, The Journal of Immunology.

[12]  C. Hoggart,et al.  Genome‐wide significance for dense SNP and resequencing data , 2008, Genetic epidemiology.

[13]  S. Amselem,et al.  A Heterozygous Mutation Disrupting the SPAG16 Gene Results in Biochemical Instability of Central Apparatus Components of the Human Sperm Axoneme1 , 2007, Biology of reproduction.

[14]  Anbupalam Thalamuthu,et al.  TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. , 2007, The New England journal of medicine.

[15]  T. Huizinga,et al.  Emerging patterns of risk factor make-up enable subclassification of rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[16]  P. Gregersen,et al.  Variation in radiologic joint destruction in rheumatoid arthritis differs between monozygotic and dizygotic twins and pairs of unrelated patients. , 2006, Arthritis and rheumatism.

[17]  F. Breedveld,et al.  The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[18]  U. Müller-Ladner,et al.  Are fibroblasts involved in joint destruction? , 2005, Annals of the rheumatic diseases.

[19]  F. Breedveld,et al.  Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[20]  J. Ware,et al.  Applied Longitudinal Analysis , 2004 .

[21]  D. M. van der Heijde,et al.  Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis , 2002, Annals of the rheumatic diseases.

[22]  R. Toes,et al.  Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10 , 2002, Annals of the rheumatic diseases.

[23]  James M Robins,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[24]  A. Zwinderman,et al.  Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage. , 2002, Arthritis and rheumatism.

[25]  S. Amselem,et al.  Isolation and expression of the human hPF20 gene orthologous to Chlamydomonas PF20: evaluation as a candidate for axonemal defects of respiratory cilia and sperm flagella. , 2002, American journal of respiratory cell and molecular biology.

[26]  P. Shekelle,et al.  How to read radiographs according to the Sharp/van der Heijde method. , 1999 .

[27]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[28]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[29]  T. Huizinga,et al.  Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic? , 2011, Rheumatology.

[30]  F. Wolfe,et al.  The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank. , 2011, Rheumatology.

[31]  C. Potter,et al.  Newcastle University E-prints Citation for Item: Baseline Serum Mmp-3 Levels in Patients with Rheumatoid Arthritis Are Still Independently Predictive of Radiographic Progression in a Longitudinal Observational Cohort at 8 Years Follow Up , 2022 .